Effect on cardiac function among patients with type 2 diabetes following high-dose mineralocorticoid receptor antagonist using echocardiography; data from the MIRAD randomized clinical trial

Peer Review reports

Original Submission
18 Feb 2022	Submitted	Original manuscript
18 Jun 2022	Reviewed	Reviewer Report
30 Nov 2022	Reviewed	Reviewer Report
7 Feb 2023	Author responded	Author comments - Caroline Kistorp
Resubmission - Version 2
7 Feb 2023	Submitted	Manuscript version 2
12 Feb 2023	Author responded	Author comments - Caroline Kistorp
Resubmission - Version 3
12 Feb 2023	Submitted	Manuscript version 3
Publishing
14 Mar 2023	Editorially accepted
31 Mar 2023	Article published	10.1186/s12872-023-03183-1

Back to article page